Home/Filings/4/0001209191-06-002039
4//SEC Filing

AMED SALAH 4

Accession 0001209191-06-002039

CIK 0000010081other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:28 PM ET

Size

23.5 KB

Accession

0001209191-06-002039

Insider Transaction Report

Form 4
Period: 2006-01-04
AMED SALAH
Sr.VP, R&D
Transactions
  • Exercise of In-Money

    Common Stock

    2006-01-04$10.05/sh+23,800$239,164161,973.96 total
  • Sale

    Common Stock

    2006-01-04$63.25/sh26,537$1,678,468135,436.96 total
  • Exercise of In-Money

    Incentive Stock Options

    2006-01-04$5.72/sh17,489$99,958362,103 total
    Exercise: $5.72From: 1998-09-12Exp: 2006-09-12Common Stock (17,489 underlying)
  • Exercise of In-Money

    Common Stock

    2006-01-04$5.71/sh+34,978$199,777135,436.96 total
  • Exercise of In-Money

    Common Stock

    2006-01-04$11.75/sh+2,737$32,163138,173.96 total
  • Exercise of In-Money

    Non-Qualified Stock Options

    2006-01-04$11.75/sh2,737$32,163341,877 total
    Exercise: $11.75From: 2000-09-11Exp: 2007-09-11Common Stock (2,737 underlying)
  • Exercise of In-Money

    Non-Qualified Stock Options

    2006-01-04$10.05/sh16,875$169,575325,002 total
    Exercise: $10.05From: 2000-09-09Exp: 2008-09-09Common Stock (16,875 underlying)
  • Exercise of In-Money

    Non-Qualified Stock Options

    2006-01-04$10.05/sh6,925$69,589318,077 total
    Exercise: $10.05From: 2001-09-09Exp: 2008-09-09Common Stock (6,925 underlying)

Issuer

BARR PHARMACEUTICALS INC

CIK 0000010081

Entity typeother

Related Parties

1
  • filerCIK 0001237250

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:28 PM ET
Size
23.5 KB